CrystalGenomics investigational compound
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CrystalGenomics investigational compound, covering 2012-12-31 to 2012-12-31. Get the full timeline:
Most recent: Clinical Trial Update: Examine Maximum Tolerated Dose and Pharmacokinetic and Pharmacodynamic Profile [Phase 1]